Is it possible to develop an animal model of fibromyalgia?
Sluka
Kathleen A
KA
Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA 52242, USA. kathleen-sluka@uiowa.edu
D018759:Adrenergic Uptake Inhibitors; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology; D004195:Disease Models, Animal; D005356:Fibromyalgia / Q000503:physiopathology*; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000502:physiology; D012110:Reserpine
D018759:Adrenergic Uptake Inhibitors; D001679:Biogenic Amines; D018377:Neurotransmitter Agents; D012110:Reserpine
Curr Pain Headache Rep. 2008 Oct;12(5):338-43
18765138
Pain. 2009 Nov;146(1-2):26-33
19646816
Pharmacol Biochem Behav. 2000 Nov;67(3):449-58
11164071
Brain Res. 2003 Mar 7;965(1-2):259-68
12591144
Brain Res Brain Res Rev. 2002 Oct;40(1-3):45-52
12589905
Neuroimmunomodulation. 2006;13(5-6):268-76
17709948
Arthritis Res Ther. 2008;10(4):211
18768089
Physiol Behav. 2006 Jun 15;88(1-2):82-7
16624346